Advertisement
Advertisement
Trending on Urology Times
1
Phase 1/2 trial launches of molecular glue degrader for ccRCC
2
Integration of doublet and triplet therapy in metastatic prostate cancer
3
Sarah Azari, MD, on early sexual health education for women with bladder cancer
4
Veda Giri, MD, on strategies to advance prostate cancer genetic testing
5